Vascular insulin response is preserved in non-diabetic patients with coronary artery disease, despite endothelial dysfunction

Scandinavian Cardiovascular Journal

Volumn 38, Issue 1, 2004, Pages 22-27

  Ihlemann, Nikolaj ^a   Rask Madsen, Christian ^b   Køber, Lars ^c   Torp Pedersen, Christian ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

^b JOSLIN DIABETES CENTER   (United States)

^c Rigshospitalet   (Denmark)

Author keywords

Coronary artery disease; Endothelial function; Insulin resistance

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FATTY ACID; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NEUTRAL INSULIN; NITRATE; NITROPRUSSIDE SODIUM; SODIUM CHLORIDE;

ADULT; ARTICLE; BIOLOGICAL MODEL; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DOSE RESPONSE; FEMALE; FOREARM BLOOD FLOW; HOMEOSTASIS; HUMAN; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN RESPONSE; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VASCULAR ENDOTHELIUM; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

ACETYLCHOLINE; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HEART RATE; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MIDDLE AGED; NITROPRUSSIDE; REGIONAL BLOOD FLOW; VASODILATION; VASODILATOR AGENTS;

EID: 1842483427     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430310016397     Document Type: Article

References (26)

1. Fontbonne AM, Eschwege EM. Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care 1991; 14: 461-469.
2. Celermajer DS. Endothelial dysfunction: Does it matter? Is it reversible? J Am Coll Cardiol 1997; 30: 325-333.
3. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235-1241.
4. Heitzer T, Schlinzig T, Krohn Y, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678.
5. Scherrer U, Sartori C. Insulin as a vascular and sympathoexcitatory hormone: Implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997; 96: 4104-4113.
6. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994; 94: 1172-1179.
7. Jiang ZY, Zhou QL, Chatterjee A, et al. Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes 1999; 48: 1120-1130.
8. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97: 2601-2610.
9. Scherrer U, Sartori C. Defective nitric oxide synthesis: A link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity. Eur J Endocrinol 2000; 142: 315-323.
10. Montagnani M, Golovchenko I, Kim I, et al. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem 2002; 277: 1794-1799.
11. Vincent D, Ilany J, Kondo T, et al. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest 2003; 111: 1373-1380.
12. Rask-Madsen C, Ihlemann N, Krarup T, et al. Insulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart disease. Diabetes 2001; 50: 2611-2618.
13. Seibaek M, Sloth C, Vallebo L, et al. Glucose tolerance status and severity of coronary artery disease in men referred to coronary artenography. Am Heart J 1997; 133: 622-629.
14. Tamaki S, Nakamura Y, Tsujita Y, Ueno M, Kinoshita M. Insulin resistance and the severity of coronary atherosclerosis. Eur Heart J 2001; 22 Abstr Suppl: 456 (p2394).
15. Hornig B, Arakawa N, Drexler H. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure. Eur Heart J 1998; 19 Suppl G: G48-G53.
16. Heeschen C, Hamm CW, Laufs U, Snapinn S, Bohm M, White HD. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 2002; 105: 1446-1452.
17. Stroes ES, Koomans HA, de Bruin TW, Rabelink TJ. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 1995; 346: 467-471.
18. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
20. Laight DW, Kaw AV, Carrier MJ, Anggard EE. Pharmacological modulation of endothelial function by insulin in the rat aorta. J Pharm Pharmacol 1998; 50: 1117-1120.
21. Steinberg HO, Tarshoby M, Monestel R, et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997; 100: 1230-1239.
22. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 1996; 98: 894-898.
23. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115.
24. Yki-Jarvinen H, Utriainen T. Insulin-induced vasodilatation: Physiology or pharmacology? Diabetologia 1998; 41: 369-379.
25. Montagnani M, Quon MJ. Insulin action in vascular endothelium: Potential mechanisms linking insulin resistance with hypertension. Diabetes Obes Metab 2000; 2: 285-292.
26. Serne EH, IJzerman RG, Gans RO, et al. Direct evidence for insulin-induced capillary recruitment in skin of healthy subjects during physiological hyperinsulinemia. Diabetes 2002; 51: 1515-1522.